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What this paper adds 
 
This study reports that one out of every five patients with carotid stenosis amenable 
to surgery exhibit inter-arm SBP difference >15 mmHg and approximately one fifth of 
those with inter-arm SBP difference suffer from subclavian or innominate artery 
stenosis. Our results therefore affirm the clinical need for inter-arm BP differences in 
patients undergoing carotid revascularization, especially in the postoperative phase in 
the prevention of cerebral hyperperfusion. 
 
  
Abstract:  
Introduction  
Blood pressure (BP) regulation is important in patients with carotid artery 
atherosclerotic disease. Concomitant subclavian artery stenosis (SAS) might 
underestimate the true systemic BP monitoring in these patients. We aimed to assess 
the prevalence of inter-arm BP difference in patients undergoing carotid intervention 
and it’s association with ipsilateral significant subclavian stenosis and clinical 
outcome. 
Methods  
Bilateral BP measurements and vascular imaging (CTA and MRA) of both subclavian 
arteries and the innominate artery were assessed in 182 symptomatic patients with 
carotid artery stenosis undergoing revascularization in the International Carotid 
Stenting Study (ICSS). Data were separately analysed according to previously 
described cut off values for systolic BP (SBP) differences of ≥ 10 and < 15 mmHg, ≥ 
15 and < 20 mmHg or  ≥ 20 mmHg. We defined significant SAS as a >50% diameter 
reduction.  
Results  
39/182 (21%) of patients showed an inter-arm difference in SBP exceeding 15 
mmHg. The mean inter-arm SBP difference associated with ipsilateral SAS was 14 
mmHg. SAS was present in 21/182 (12%) patients. Only two patients (1%) had 
bilateral stenotic disease. An inter-arm SBP difference of ≥ 20 mmHg was associated 
with unilateral SAS (RR 11.8; 95% CI 3.2 – 43.1) with a sensitivity of 23% and a 
specificity of 98%. Patients were followed up for a median of 4.0 years (IQR 3.0 – 6.0; 
maximum 7.5). Risk of stroke or death during follow-up was 20.0% (95% CI 11.1-
28.9) in patients with and 15.1% (95% CI 12.3-17.9) in patients without SAS 
(p=0.561). The length of stay in hospital was longer in patients with significant SAS 
(5.0 days; SD 4.9 vs. 2.7 days; SD 4.3 [p=0.035]) 
Conclusion 
Our study is the first to affirm the clinical need for inter-arm BP differences in patients 
undergoing carotid revascularization, especially in the postoperative phase in the 
prevention of cerebral hyperperfusion.   
Introduction  
 
Blood pressure (BP) regulation plays an important role in the management of 
patients with cerebrovascular disease. A recent analysis showed that adequate 
implementation of 2014 hypertension guidelines could potentially prevent 37,400 
strokes annually in the U.S.1  
Haemodynamic instability is observed in 13% - 23% of patients undergoing 
carotid endarterectomy (CEA) 2,3,4, and is associated with poor perioperative 
outcomes as well as an increased 1-year stroke or death rate. 3,4 Peri-procedural 
haemodynamic depression in patients treated by carotid artery stenting (CAS), is 
associated with an excess of new ischaemic brain lesions. In general, patients 
undergoing carotid intervention under general anaesthesia are more likely to be 
exposed to intra-procedural hypotension and post-procedural hypertension.5 Intra- 
and post-procedural management should therefore include careful control of BP to 
protect patients from severe periprocedural hypotension and postoperative cerebral 
hyperperfusion. 6 
Current guidelines suggest non-invasive bilateral BP measurement at the level 
of the arteria brachialis.7,8 However, in daily practice these guidelines may be 
neglected with BP often being measured only in the arm that is most accessible at the 
time of examination. Systolic BP difference is often related to anatomic correlation 
between atheromatous disease in the carotid, subclavian or the innominate artery. 
Patients with carotid artery disease often have multilevel atherosclerotic pathology 
including the origin of the subclavian arteries. In bilateral compromised outflow in the 
subclavian arteries, even in the presence of a left right BP difference, this may still 
underestimate the central aortic pressure.  Given that guidelines recommend 
treatment of hypertension to specific targets on the basis of BP readings, 
underestimation of BP might lead to inadequate treatment of hypertension. To the 
best of our best knowledge, no previous study has ever focused before on the 
existence of BP differences in patients undergoing carotid revascularization. 
We aimed to assess the prevalence of baseline upper extremity BP difference 
in relation to the presence of subclavian artery or innominate artery stenosis in 
patients undergoing carotid revascularization.   
  
Methods 
 
Patients  
All patients participating in the International Carotid Stenting Study (ICSS), who were 
treated in the University Medical Center Utrecht (UMCU) between 2003 and 2009, 
were included in this study. The methods of this multicentre RCT (ISRCTN 25337470) 
have been described previously. In summary, patients with recently symptomatic 
moderate or severe carotid stenosis (≥50% reduction of the lumen diameter according 
to the NASCET method) were randomly assigned to receive either carotid artery 
stenting or endarterectomy in a 1:1 ratio. In ICSS vascular imaging of the cerebral 
and supra-aortic vessels was required prior to randomization. For the purpose of this 
study, patients were only included if bilateral BP measurements were available and if 
the quality of vascular imaging allowed us to reliably detect and quantify the degree of 
potential subclavian stenosis. A total of 1713 patients were enrolled in ICSS, of which 
270 patients were randomized in the UMCU.  
   
Blood pressure measurements 
Systolic blood pressure (SBP) and Diastolic blood pressure (DBP) were measured 
non-invasively at the time of randomization or during the patient’s first visit to the 
outpatient clinic. Measurements were done according to physician preference using 
either manual or automated devices. Although this was not systematically recorded, 
the automatic device was usually the preferred method with the patient in supine 
position. The inter-arm BP difference was calculated using the following formula: 
[SBPhighest] – [SBPlowest]. Data were separately analysed according to previously 
described cut off values for SBP differences of  10 and < 15 mmHg,  15 and < 20 
mmHg or   20 mmHg.9,10,11 An difference in SBP of <10 mmHg was considered an 
equal BP in both arms.  
  
Assessment of baseline imaging 
Among 270 patients, 46 did not have documented bilateral BP assessment. Available 
vascular imaging at randomisation did not allow assessment of the subclavian 
arteries, in 42 patients. Of the remaining 182 patients, vascular imaging was 
performed with Computed Tomography Angiography (CTA) in 104 patients (57%), 
Magnetic Resonance Angiography (MRA) in 77 patients (42%) and conventional 
angiography in one patient (0.5%). The assessment of baseline imaging was 
performed by one radiologist (SP), who was blinded to treatment allocation and the 
presence of BP difference. The extent of stenosis for both subclavian arteries and the 
innominate artery (i.e. the brachiocephalic trunk) was assessed, using criteria based 
on the North American Symptomatic Carotid Surgery Trial (NASCET). We classified 
patients in the following 5 categories: (1) no atherosclerotic lesion; or stenosis 
measuring: 2) 1-24%; 3) 25-49%; 4) 50%-74%; and 5) 75-100%.  We defined 
significant stenosis as a reduction in vessel diameter of > 50%. 
 
Procedural (<30 days) and long term outcome 
In ICSS major outcome events were adjudicated by an independent endpoint 
committee that was unaware of treatment allocations. Stroke was defined as a rapidly 
developing clinical syndrome of focal disturbance of cerebral function lasting more 
than 24 hours or leading to death with no apparent cause other than that of vascular 
origin. For the present analysis, medical records were reviewed to assess the number 
of patients in whom treatment of BP was necessary after the procedure. We further 
classified patients according to the location at which BP treatment was given: 
vascular ward or medical care unit.  
 
 
Statistical Analysis 
We compared SAS as a dichotomous outcome, between groups defined by inter-arm 
SBP difference with a threshold of either  10 mmHg,  15 mmHg and  20 
mmHg.9,10,11 A Chi-square test was used to compare the presence of ipsilateral SAS  
between patients with and without inter-arm SBP difference. Continuous variables 
were compared with the Mann-Whitney U test. Relative risks for the presence of 
ipsilateral SAS in relation to inter-arm SBP difference were calculated. P- values of 
<0.05 were considered statistically significant.  
Results 
 
Inter-arm blood pressure differences 
The mean SBP in 182 patients was 165 mmHg (range 100 - 230). For 116 patients 
(64%), SBP was equal (<10 mmHg) in both arms (mean SBP 164, range 107 - 220). 
In the remaining 96 patients, inter-arm blood pressure difference in SBP ranged from 
1 mmHg to 35 mmHg with a mean inter-arm SBP difference of 6.94 mmHg. In 39/182 
(21%) the inter-arm SBP difference exceeded the 15 mmHg (range 15 – 35) (table 1).  
 
Subclavian artery and innominate artery stenosis 
Overall, a >50% subclavian or innominate stenosis was present in 21/182 patients 
(12%). In 8 patients unilateral disease consisted of a right subclavian or innominate 
artery stenosis. In 11 patients unilateral disease consisted of a left subclavian 
stenosis. Two patients (1%) had bilateral stenotic disease. In 1 patient bilateral 
disease consisted of a left subclavian stenosis and innominate artery stenosis. The 
remaining patient presented with a bilateral SAS. (table 2) No reversed flow in the 
vertebral arteries was detected among the 21 patients with >50% subclavian or 
innominate stenosis.      
 
Inter-arm blood pressure differences in relation to subclavian stenosis 
In 10/21 patients with SAS, a lower SBP was measured ipsilateral to the stenosis in 
cases of unilateral disease and ipsilateral to the most severe stenosis in cases of 
bilateral disease. In the remaining 11 patients, no BP difference (n=8) or a higher BP 
was measured ipsilateral to the stenosis (n=3). The sensitivity of the finding of a lower 
SBP to detect ipsilateral SAS with a threshold of ≥10 mmHg was 14%, for a threshold 
of ≥15 mmHg 18% and for a threshold of ≥ 20 mmHg 23%. Specificity was 
respectively 99%, 98% and 98% (table 3). The mean inter-arm SBP difference in 
patients with SAS was 14.21 mmHg. On average, the mean inter-arm SBP difference 
was higher in those patients with more severe stenosis (table 4). We found a RR of 
11.8 (95% CI 3.2 – 43.1) for SAS of more than 50% and a SBP difference of ≥ 20 
mmHg. RR measurements for other SBP thresholds are presented in table 5.   
 
Procedural (<30 days) and long-term outcome 
In our cohort, a total of 9 (4.9%) procedural strokes occurred. The most likely 
mechanism of stroke in these patients were as follows: hyperperfusion (n=3), 
hypoperfusion (n=2), thrombo-embolic (n=2), ipsilateral carotid occlusion (n=1), 
cardio-embolic (n=1). The rate of procedural stroke was non-significantly higher in 
patients with SAS compared to patients without SAS, respectively 2/21 (9.5%) and 
7/161 (4.3%) (p=0.62). Among 3/9 (33%) patients with procedural stroke a SBP 
difference was present. All strokes in patients with a SBP difference were caused by 
hyperperfusion. Patients were followed up for a median of 4.0 years (IQR 3.0 – 6.0; 
maximum 7.52). Kaplan Meier life table analysis showed a similar cumulative risk of 
stroke or death during follow-up in patients with (20.0%; 95% CI 11.1-28.9) and 
without SAS (15.1%; 95% CI 12.3-17.9) (p=0.56). In patients with a SBP difference of 
≥ 15 mmHg the cumulative risk of stroke or death during follow-up was 13.2% (95% 
CI 7.7-18.7) as compared to 16.3% (95% CI 13.2-19.4) in patients with equal SBP or 
a SBP difference of ≤ 15 mmHg (p=0.64).  
 
 
 
Blood pressure management in the procedural (<30 days) period 
In 168 of 182 patients (20 with and 148 without significant SAS), data was available 
on peri-procedural BP management. The amount of patients in which a BP 
intervention was encountered requiring medical treatment was similar in patients with 
(5/20; 25%) and without (24/148; 16%) SAS (p=0.51). Ten percent (2/20) of patients 
with SAS were admitted to the medium care unit for intravenous BP regulation 
compare to 4% (6/148) of patients without SAS (p=0.50). Patients with SAS admitted 
to the medium care had a longer hospital stay (5.0 days; SD 4.9 vs. 2.7 days; SD 4.3 
[p=0.04])  
 
Discussion  
 
As far as we are aware, the present study was the first to assess the 
prevalence of upper extremity BP differences in relation to SAS  in patients 
undergoing carotid revascularization. One out of five patients showed an interarm 
SBP difference exceeding 15 mmHg. An inter-arm SBP difference  of 15 mmHg or 
higher was associated with ipsilateral SAS > 50%, but showed a low sensitivity and 
high specificity. In this cohort, the prevalence of patients with a bilateral compromised 
outflow in the subclavian artery was very low (1%). No association was found 
between SAS and 30-day stroke rate or stroke or death rate during follow-up, but the 
mean length of stay in hospital was longer in these patients. The prevalence rates 
presented in our study are in agreement with the findings in previous secondary care 
populations. 12,13  
A recent meta-analysis investigated whether an association between SBP 
differences and central or peripheral vascular disease existed. 9 The pooled findings 
of five studies, including individuals with raised cardiovascular risk, showed a strong 
association between angiographically proven SAS  and an inter-arm SBP difference  
of 10 mmHg or more (RR 8.8, 95% CI 3.6 – 21.2).9 The RR for a threshold of 10 
mmHg in our study was twice as high, but should be interpreted cautiously, because 
of the width of confidence intervals. 
In nine out of ten patients with equal SBP, no significant SAS was present. 
However, even in patients with equal BP, although very scarce, bilateral subclavian 
stenosis can still be present. In this subgroup of patients, BP measurements 
represent a lower value than the true systemic BP. Furthermore, potentially co-
existing aortic or ilio-femoral stenosis may influence the reliability of BP 
measurements at the lower extremity. In such cases, intravascular BP readings 
should be performed to reliably detect haemodynamic disturbances during the 
procedure.  
In the International Carotid Stenting Study (ICSS) haemodynamic depression 
occurred in 13.8% of cases after carotid artery stenting (CAS), and in 7.2% of cases 
after carotid endarterectomy (CEA). In patients treated by CAS, peri-procedural 
haemodynamic depression was associated with an excess of new ischaemic brain 
lesions.2,15 A further detailed analysis of procedural strokes in this randomized trial 
showed that one third of procedural strokes were caused by peri-procedural 
haemodynamic disturbances, suggesting that careful attention to blood pressure 
control could further lower the risk of this procedural complication.14 In this context it is 
interest to note that in our study, all patients with procedural strokes caused by 
hyperperfusion, were known to have a SBP difference. While all patients with 
procedural strokes not related to hyperperfusion had equal SBP.  
Our study has several limitations. First of all, due to its retrospective character 
bilateral BP measurements were not performed in 46 patients. This finding 
emphasizes the need for firm recommendations to measure blood pressure on both 
arms in all CEA patients. Secondly, the method of measurement used was sequential 
rather than simultaneous. In sequential blood pressure measurement the so called 
‘white coat-effect’ could contribute to the amount of blood pressure difference 
recorded, in which the first measurement is higher than the second.16 However, our 
results showed an association between inter-arm blood pressure difference in SBP 
and subclavian stenosis, making it less likely that recorded differences were 
attributable to a ‘white coat-effect’. Thirdly, the mean SBP in our subgroup of patients 
was much higher than the mean SBP in ICSS (165 mmHg vs 147 mmHg), indicating 
poor control of hypertension in our patients.  
 
In conclusion, within this single centre study about one out of every five 
patients with carotid artery stenosis undergoing revascularization within an 
international RCT, did not have a documented bilateral assessment of the blood 
pressure. Of those patients with bilateral measurements we found a high prevalence 
of inter-arm blood pressure difference sin SBP and this was strongly associated with 
the presence of ipsilateral significant subclavian stenosis. In line with guidelines on 
the treatment of patients undergoing carotid revascularization this study reaffirms the 
need for non-invasive bilateral blood pressure measurements in all patients 
undergoing carotid intervention. The prevalence of patients with a bilateral 
compromised outflow in the subclavian stenosis was very low in our cohort. This 
suggests that it is safe to consider the highest measurement as the true blood 
pressure.  
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 Legends of Figures 
 
Figure 1 Flow chart of patients included in the present analysis 
 
  
Table 1 Number of patients with inter-arm blood pressure differences (SBP, systolic 
blood pressure difference) 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Number of patients (%) 
(n=182)  
 
SBP inter-arm difference  
- <10 mmHg  
- 10 - 14 mmHg 
- 15 - 19 mmHg 
- ≥ 20 mmHg  
 
 
116 (64) 
27 (15) 
9 (5) 
30 (16) 
 
  
Table 2. Sites and number of patients (%) with significant (>50%) stenosis (n=182)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Site of stenosis right sided  
stenosis 
left sided  
stenosis 
bilateral  
stenosis 
- Subclavian stenosis 6 (3.0%) 11 (6.0%) 1 (0.5%) 
 
- Innominate stenosis 2 (1.0%) n/a n/a 
- Left subclavian and 
innominate stenosis 
n/a n/a 1 (0.5%) 
- Bilateral subclavian and 
innominate stenosis 
n/a n/a 0 (0.6%) 
  
 
 
 
 
 
 
 
  
 Table 3 Systolic blood pressure interarm differences in relation to ipsilateral 
haemodynamic significant (>50%) subclavian or innominate stenosis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
≥ 10 
mmHg 
n=66 (%) 
 
≥ 15 
mmHg 
n=39 (%) 
 
≥ 20 
mmHg 
n=30 (%) 
 
- Ipsilateral stenosis 
 
- No ipsilateral 
stenosis 
 
 
9 (14) 
 
57 (86)   
 
 
7 (18) 
 
32 (82) 
 
 
7 (23) 
 
23 (77) 
 
Table 4.  Comparison of mean systolic blood pressure (SBP) difference in patients 
with and without stenosis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
* p-value derived by use of the t-test comparing mean SPB difference between patients with  
and without stenosis.  
 
 
 
 
 
 
 
 
 
 Mean SBP difference (mmHg) 
    With stenosis        without 
stenosis 
 
    p-value* 
 
- Stenosis 0-25% 
 
- Stenosis 25-50% 
 
- Stenosis 50-75% 
 
- Stenosis 75-100% 
 
 
6.09 
 
4.78 
 
12.22 
 
23.33 
 
7.80 
 
7.94 
 
6.59 
 
6.87 
 
0.224 
 
0.045 
 
0.014 
 
0.002 
 Table 5. Systolic blood pressure inter-arm difference in relation to ipsilateral 
subclavian stenosis 
 
  
Stenosis / total 
 
Difference ≥  mmHg   
 
 
 
Difference < 
mmHg 
 
*Relative Risk (95% 
CI) 
 
 
- ≥ 10 mmHg 
 
- ≥ 15 mmHg 
 
9 / 66 
 
 
1/116 
 
 
15.8 (2.0 – 122.1) 
 
 * Relative risk ratios for ipsilateral subclavian or innominate stenosis in patients with and 
without differences in systolic blood pressure of respectively ≥10 mmHg, ≥15 mmHg and ≥20 
mmHg between arms.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- ≥ 20 mmHg 
 
7/39 
 
7/30 
3/143 
 
3/152 
8.6 (2.3 – 31.6) 
 
11.8 (3.2 – 43.1) 
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